F
47
4
AEE
64
4
ALL
51
8
FRT
45
6
ADI
47
2
HPE
61
6
AXP
69
3
TRV
56
3
RRC
59
-4
ADP
66
2
HST
58
18
SWK
61
5
BRK.B
42
2
PBI
65
5
DE
56
10
STZ
57
2
EFX
36
4
IBM
60
6
VNO
50
-9
SYY
49
2
F
47
4
AEE
64
4
ALL
51
8
FRT
45
6
ADI
47
2
HPE
61
6
AXP
69
3
TRV
56
3
RRC
59
-4
ADP
66
2
HST
58
18
SWK
61
5
BRK.B
42
2
PBI
65
5
DE
56
10
STZ
57
2
EFX
36
4
IBM
60
6
VNO
50
-9
SYY
49
2
Financhill
Back

Clearside Biomedical 10K Form

Sell
31

CLSD
Clearside Biomedical

Last Price:
1.03
Seasonality Move:
25.1%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive CLSD News And Ratings

See the #1 stock for the next 7 days that we like better than CLSD

CLSD Financial Statistics

Sales & Book Value

Annual Sales: $8.23M
Cash Flow: $-5.97M
Price / Cash Flow: 0
Annual Sales: $-0.47
Price / Book: 0

Profitability

EPS (TTM): -0.45000
Net Income (TTM): $-31.88M
Gross Margin: $7.87M
Return on Equity: 0%
Return on Assets: -92.84%

Clearside Biomedical Earnings Forecast

Key Clearside Biomedical Financial Ratios

  • The Gross Profit Margin over the past 5 years for CLSD is 95.68%.
  • The Selling, General & Administrative Expenses for CLSD have been equal to 144.29% of Gross Profit Margin.
  • The Research & Development expenses have been 253.42% of Revenue.
  • The Interest Expense is -28.81% of Operating Income.
  • The Net Earning history of CLSD is -394.91% of Total Revenues.
  • Per Share Earnings over the last 11 years have been positive in 4 years.

Clearside Biomedical Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Pharmaceuticals
Sector: Health Care
Current Symbol: CLSD
CUSIP: 185063
Website: clearsidebio.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 4.49
Quick Ratio: 4.36

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

CLSD Technical Analysis vs Fundamental Analysis

Sell
31
Clearside Biomedical (CLSD) is a Sell

Is Clearside Biomedical a Buy or a Sell?